340 related articles for article (PubMed ID: 15522281)
1. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis.
Wang Y; Ahmad N; Wani MA; Ashraf M
J Mol Cell Cardiol; 2004 Nov; 37(5):1041-52. PubMed ID: 15522281
[TBL] [Abstract][Full Text] [Related]
2. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice.
Li Y; Takemura G; Kosai K; Yuge K; Nagano S; Esaki M; Goto K; Takahashi T; Hayakawa K; Koda M; Kawase Y; Maruyama R; Okada H; Minatoguchi S; Mizuguchi H; Fujiwara T; Fujiwara H
Circulation; 2003 May; 107(19):2499-506. PubMed ID: 12695295
[TBL] [Abstract][Full Text] [Related]
3. Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis.
Kobayashi H; Yasuda S; Bao N; Iwasa M; Kawamura I; Yamada Y; Yamaki T; Sumi S; Ushikoshi H; Nishigaki K; Takemura G; Fujiwara T; Fujiwara H; Minatoguchi S
J Cardiovasc Pharmacol; 2009 Dec; 54(6):510-9. PubMed ID: 19755919
[TBL] [Abstract][Full Text] [Related]
4. The role of cytoprotective cytokines in cardiac ischemia/reperfusion injury.
Anderson CD; Heydarkhan-Hagvall S; Schenke-Layland K; Yang JQ; Jordan MC; Kim JK; Brown DA; Zuk PA; Laks H; Roos KP; Maclellan WR; Beygui RE
J Surg Res; 2008 Aug; 148(2):164-71. PubMed ID: 18067924
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of integrin-linked kinase attenuates left ventricular remodeling and improves cardiac function after myocardial infarction.
Ding L; Dong L; Chen X; Zhang L; Xu X; Ferro A; Xu B
Circulation; 2009 Sep; 120(9):764-73. PubMed ID: 19687354
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction.
Odashima M; Usui S; Takagi H; Hong C; Liu J; Yokota M; Sadoshima J
Circ Res; 2007 May; 100(9):1344-52. PubMed ID: 17395874
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor and granulocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
Guo YH; He JG; Wu JL; Yang L; Zhang DS; Tan XY; Qi RD
Cytotherapy; 2008; 10(8):857-67. PubMed ID: 18956268
[TBL] [Abstract][Full Text] [Related]
8. Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction.
Sumida A; Horiba M; Ishiguro H; Takenaka H; Ueda N; Ooboshi H; Opthof T; Kadomatsu K; Kodama I
Cardiovasc Res; 2010 Apr; 86(1):113-21. PubMed ID: 19969622
[TBL] [Abstract][Full Text] [Related]
9. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway.
Tang J; Wang J; Kong X; Yang J; Guo L; Zheng F; Zhang L; Huang Y; Wan Y
Exp Cell Res; 2009 Dec; 315(20):3521-31. PubMed ID: 19800880
[TBL] [Abstract][Full Text] [Related]
11. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction.
Deuse T; Peter C; Fedak PW; Doyle T; Reichenspurner H; Zimmermann WH; Eschenhagen T; Stein W; Wu JC; Robbins RC; Schrepfer S
Circulation; 2009 Sep; 120(11 Suppl):S247-54. PubMed ID: 19752375
[TBL] [Abstract][Full Text] [Related]
13. Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction.
Hu CH; Wu GF; Wang XQ; Yang YH; Du ZM; He XH; Xiang P
Chin Med J (Engl); 2006 Sep; 119(18):1499-506. PubMed ID: 16996002
[TBL] [Abstract][Full Text] [Related]
14. Gene transfection with human hepatocyte growth factor complementary DNA plasmids attenuates cardiac remodeling after acute myocardial infarction in goat hearts implanted with ventricular assist devices.
Shirakawa Y; Sawa Y; Takewa Y; Tatsumi E; Kaneda Y; Taenaka Y; Matsuda H
J Thorac Cardiovasc Surg; 2005 Sep; 130(3):624-32. PubMed ID: 16153905
[TBL] [Abstract][Full Text] [Related]
15. Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure.
Jayasankar V; Woo YJ; Pirolli TJ; Bish LT; Berry MF; Burdick J; Gardner TJ; Sweeney HL
J Card Surg; 2005; 20(1):93-101. PubMed ID: 15673421
[TBL] [Abstract][Full Text] [Related]
16. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction.
Morimoto H; Takahashi M; Izawa A; Ise H; Hongo M; Kolattukudy PE; Ikeda U
Circ Res; 2006 Oct; 99(8):891-9. PubMed ID: 16990567
[TBL] [Abstract][Full Text] [Related]
17. Leukemia inhibitory factor enhances survival of cardiomyocytes and induces regeneration of myocardium after myocardial infarction.
Zou Y; Takano H; Mizukami M; Akazawa H; Qin Y; Toko H; Sakamoto M; Minamino T; Nagai T; Komuro I
Circulation; 2003 Aug; 108(6):748-53. PubMed ID: 12860906
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival.
Zaruba MM; Huber BC; Brunner S; Deindl E; David R; Fischer R; Assmann G; Herbach N; Grundmann S; Wanke R; Mueller-Hoecker J; Franz WM
Cardiovasc Res; 2008 Mar; 77(4):722-31. PubMed ID: 18055578
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte colony stimulating factor/macrophage colony stimulating factor improves postinfarct ventricular function by suppression of border zone remodelling in rats.
Miki T; Miura T; Nishino Y; Yano T; Sakamoto J; Nakamura Y; Ichikawa Y; Ikeda Y; Kobayashi H; Ura N; Shimamoto K
Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):873-82. PubMed ID: 15659052
[TBL] [Abstract][Full Text] [Related]
20. Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction.
Yang ZJ; Ma DC; Wang W; Xu SL; Zhang YQ; Chen B; Zhou F; Zhu TB; Wang LS; Xu ZQ; Zhang FM; Cao KJ; Ma WZ
Gene Ther; 2006 Nov; 13(22):1564-8. PubMed ID: 16810195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
